AKT1 and SHORT syndrome: In previous reports, PI3K p85 with mutations in the cSH2 domain have been shown to attenuate PI3K–Akt signaling via defective binding to RTKs and to cause SHORT syndrome, which is characterized mainly by growth and developmental failure, abnormal glucose metabolism, and diabetes (42, 43).